REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Cong Ty Co Phan Duoc Khoa (Vietnam)

Main Activities: Pharmaceutical Preparation Manufacturing
Full name: Cong Ty Co Phan Duoc Khoa Profile Updated: June 07, 2022
Buy our report for this company USD 19.99 Most recent financial data: 2022 Available in: English Download a sample report

Cong Ty Co Phan Duoc Khoa is engaged in provision and distribution of pharmaceutical products and health care products. The company offers products such as eye drops, drops and nasal spray, products for children and other related products. The company was incorporated in 2001 and is based in Ha Noi, Vietnam.

Legal Address
No 9 Nguyen Cong Tru,Pham Dinh Ho Ward,Hai Ba Trung District
Ha Noi (municipality); Red River Delta;

Contact Details: Purchase the Cong Ty Co Phan Duoc Khoa report to view the information.

Website: http://www.dkpharma.vn

Basic Information
Total Employees:
Purchase the Cong Ty Co Phan Duoc Khoa report to view the information.
Outstanding Shares:
Purchase the Cong Ty Co Phan Duoc Khoa report to view the information.
Financial Auditors:
Purchase the Cong Ty Co Phan Duoc Khoa report to view the information.
Incorporation Date:
2002
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Purchase this report to view the information.
Director
Ownership Details
Purchase this report to view the information.
11.38%
Company Performance
Financial values in the chart are available after Cong Ty Co Phan Duoc Khoa report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency VND. Absolute financial data is included in the purchased report.
Net sales revenue
34.92%▲
Total operating revenue
34.92%▲
Operating profit (EBIT)
1.15%▲
Net Profit (Loss) for the Period
-7.6%▼
Total assets
4.41%▲
Total equity
4.19%▲
Operating Profit Margin (ROS)
-2.25%▼
Net Profit Margin
-0.99%▼
Return on Equity (ROE)
-0.7%▼
Debt to Equity Ratio
50.36%▲
Quick Ratio
0.06%▲
Cash Ratio
0.05%▲

To view more information, Request a demonstration of the EMIS service

USD 19.99
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo